ELIZABETH HELGANS: Open Payments
NPI 1174664825 · BOULDER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,054 in 42 payments from 12 companies in 2025. Trend: 2023 $576 · 2024 $652 · 2025 $1,054
Food & beverage: $1,054
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $206 |
| ABBVIE INC. | 8 | $156 |
| Madrigal Pharmaceuticals | 2 | $123 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $113 |
| Regeneron Healthcare Solutions, Inc. | 4 | $100 |
| Aimmune Therapeutics, Inc. | 4 | $89 |
| Braintree Laboratories, Inc. | 3 | $67 |
| PFIZER INC. | 3 | $65 |
| GENZYME CORPORATION | 2 | $56 |
| Intercept Pharmaceuticals, Inc. | 2 | $38 |
Products named: TREMFYA, DUPIXENT, REZDIFFRA, ENTYVIO, RINVOQ, ZENPEP, SUFLAVE, XELJANZ.
Industry payments across CO — which companies pay providers there.
